Home
Strategy
Team
Portfolio
News
Contact
More
OCV PARTNERS ASSISTS PORTFOLIO COMPANY SOCIAL NATIVE IN ACQUIRING OLAPIC TO CREATE NEXT-GEN CREATIVE OPTIMIZATION PLATFORM
OCV PARTNERS PARTICIPATES IN FINCH THERAPEUTICS’ OVERSUBSCRIBED $90 MILLION FINANCING TO ADVANCE ITS PIPELINE OF INVESTIGATIONAL ORAL MICROBIOME DRUGS
SAFEBREACH RAISES $19 MILLION TO EXPAND CHANNELS, ACCELERATE PRODUCT DEVELOPMENT
OCV PARTNERS CO-LEADS BY HEART’S $70M SERIES A FINANCING AHEAD OF FIRST PRODUCT LAUNCH IN 2021
OSSIO RECEIVES FDA 510(K) CLEARANCE FOR OSSIOFIBER® HAMMERTOE FIXATION SYSTEM
FINCH THERAPEUTICS COMPLETES ENROLLMENT IN POTENTIALLY PIVOTAL TRIAL OF CP101, AN INVESTIGATIONAL ORAL FULL-SPECTRUM MICROBIOTA® THERAPY FOR THE PREVENTION OF RECURRENT C. DIFFICILE INFECTION
FINCH THERAPEUTICS RAISES $53 MILLION TO ADVANCE MICROBIOME-BASED THERAPIES FOR RECURRENT C. DIFFICILE, AUTISM AND OTHER DISEASE AREAS
MUSEUM OF ICE CREAM FOUNDERS LAUNCH FIGURE8 WITH SERIES A TO TRANSFORM HOW MILLENNIALS AND GEN-Z CONNECT WITH SPACES AND EACH OTHER
OSSIO SECURES $22 MILLION IN FINANCING
PRECISION BIOSCIENCES RAISES $110M TO ADVANCE ARCUS GENOME EDITING PROGRAMS
INVOICE2GO RAISES $10 MILLION, ATTRACTING NEW AND EXISTING INVESTORS, AND HEMI ZUCKER FROM OCV PARTNERS TO JOIN THE BOARD OF DIRECTORS
HEMI ZUCKER TO JOIN OCV MANAGEMENT AS MANAGING PRINCIPAL
PRAXIS PRECISION MEDICINES ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING AND EXERCISE IN FULL OF THE UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES
ORCA AI, WHICH PUTS COMPUTER VISION ONTO CARGO SHIPS, RAISES $13M SERIES A FUNDING
OSSIO AWARDED FDA 510(K) CLEARANCE FOR OSSIOFIBER® COMPRESSION SCREW PORTFOLIO
FINCH THERAPEUTICS ANNOUNCES POSITIVE TOPLINE RESULTS FROM RANDOMIZED CONTROLLED TRIAL OF CP101, AN ORAL MICROBIOME DRUG, FOR THE PREVENTION OF RECURRENT C. DIFFICILE INFECTION
FINCH THERAPEUTICS ANNOUNCES PRICING OF UPSIZED INITIAL PUBLIC OFFERING
